Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Cue BiopharmaCUE | Open-market buy | 25/12/30 | 01/02 | 323,857 sh5 trades | $0.31avg. | $99,719.49 | No record | |
Cue BiopharmaCUE | Open-market buy | 24/12/16 | 24/12/18 | 30,000 sh | $1.03 | $30,900 | +22.3% | |
Anish SuriPresident and Cso | Cue BiopharmaCUE | Open-market buy | 23/08/25 | 23/08/29 | 4,000 sh | $2.76 | $11,040 | +3.0% |
Cue BiopharmaCUE | Open-market buy | 23/08/14 | 23/08/16 | 3,000 sh | $2.86 | $8,580 | +2.3% | |
Peter A. KienerDirector | Cue BiopharmaCUE | Open-market sale | 23/03/23 | 23/03/27 | 9,325 sh | $3.28 | $30,586 | −96.3% |